Previous Article | Next Article ![]()
J. Virol., Aug 1995, 4628-4632, Vol 69, No. 8
MB Gomez and JE Hildreth
We have shown that a monoclonal antibody to the cell surface adhesion
molecule LFA-1 (CD18/CD11a) enhances plasma neutralization of a laboratory
isolate (HIVMN) and a primary isolate (HIV28R) of human immunodeficiency
virus type 1. Human phytohemagglutinin blasts were infected with HIVMN or
HIV28R in the presence of plasma pooled from HIV- positive individuals
(AIDS plasma) or immunoglobulin G from AIDS plasma alone or combined with a
monoclonal antibody (MAb) to LFA-1. While AIDS plasma alone at a dilution
of 1:1,250 neutralized HIVMN and HIV28R infection by 15 and 0%,
respectively, in the presence of a saturating concentration of the MAb to
LFA-1 the plasma neutralized both viruses by more than 80% at this
dilution. Immunoglobulin G purified from AIDS plasma, when used in
combination with the MAb to LFA-1, showed the same synergistic effect in
HIV neutralization as seen with the AIDS plasma and anti-LFA-1. The MAb
against LFA-1 partially neutralized both viral isolates (45 to 55%) on its
own. These results demonstrate significant synergy between the plasma and
antibody against LFA-1 in the neutralization of HIV. The observations
therefore suggest an important role for adhesion molecules in HIV
infectivity and transmission. The results have implications for the
recently observed host effect on HIV susceptibility to antibody
neutralization.
Copyright © 1995, American Society for Microbiology
Antibody to adhesion molecule LFA-1 enhances plasma neutralization of human immunodeficiency virus type 1
Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|